October 2018 Healthcare Deal Spending Breaks Even

Spending on healthcare deals in the month of October didn’t match the surge in deal volume (see separate post). At $9.4 billion, October 2018 posted a slight 4% gain over September, but was 25% lower than the $12.6 billion spent in October 2017. Of course, we can only go by disclosed prices, and several transactions […]

Disruption Hits the Digital Health Sector

Retailers have been the big disruptors in the healthcare market in recent months, but not in digital health. CVS Health (NYSE: CVS) and Aetna‘s (NYSE: AET) merger, announced in December 2017, is still on track. Amazon‘s (NASDAQ: AMZN) deal for PillPack has many wondering what’s next in the online pharmaceutical space. Now there’s Best Buy […]

Sperm and Egg Bank Merges with Stem Cell Company

June is thought to be the most popular month for weddings, and new beginnings. That wasn’t what sparked the merger of California Cryobank and Cord Blood Registry (CBR) on June 15, but it certainly put marriage and families front and center. California Cryobank, a portfolio company of Longitude Capital and NovaQuest Capital, is the world’s leading […]

Watering garden
Watering garden

Digital Health Deals Are Blooming

The eHealth sector is on a roll, and the momentum seems to be gaining every month. Deal volume in the first quarter of 2018, at 45 announced transactions, was 50% higher than in the fourth quarter of 2017. With only four deals fewer than the same quarter in 2017, the 8% dip in deal volume […]

Dermatology Deals Keep PE Platforms Growing

The Physician Medical Group sector has been very busy in recent years, as hospitals and health systems acquire local practices that can produce referrals and private equity firms build platforms and make add-on deals. Dermatology practices aren’t coveted by hospitals, so it’s the private equity firms that are doing the collecting. In the first eight […]

Charles River Labs Adds MPI Research

The CRO deals just keep coming. Four have been announced since the beginning of the year,  targeting contract research organizations (CROs). The latest announcement came from Charles River Laboratories International (NYSE: CRL), which is paying $800 million for Mattawan, Michigan-based MPI Research. This is the highest disclosed price for an acquisition by Charles River since 2011. […]